Target intelligence / Profile preview

Novel transcript, antisense to MIER3

Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

ENSG00000271828, also known as "Novel transcript, antisense to MIER3," is a long non-coding RNA (lncRNA) gene encoded antisense to the coding gene MIER3. It belongs to the lncRNA class and does not code for a protein product. While the function of many antisense lncRNAs involves regulation of neighboring gene expression through processes such as chromatin modification, RNA stability, or transcriptional interference, there are currently no specific mechanistic or disease associations reported for this transcript. It is not classified as a therapeutic target such as a receptor, enzyme, transporter, or similar molecule. ENSG00000271828 is annotated by GeneCards as an RNA gene of the lncRNA class. There is currently no literature or database evidence linking this specific lncRNA to therapeutic targeting, drug interaction, or known disease roles. Antisense lncRNAs are known in general to participate in various regulatory processes, but individual function for this transcript remains uncharacterized as of current profiling. The MIER3 gene, by contrast, is a protein-coding gene involved in chromatin regulation and cancer, but this is not the focus here.

Other names
ENSG00000271828lncRNA antisense to MIER3
02

Biological functions

Possible regulation of MIER3 gene expressionEpigenetic regulation (inferred from generic role of antisense lncRNAs)
03

Disease associations

Other (no specific disease associations as of current knowledge)

Beyond the preview

Go deeper on Novel transcript, antisense to MIER3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to MIER3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call